Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta

被引:17
作者
Kocijan, Roland [1 ]
Muschitz, Christian [1 ]
Fratzl-Zelman, Nadja [2 ]
Haschka, Judith [1 ]
Dimai, Hans-Peter [3 ]
Trubrich, Angela [1 ]
Bittighofer, Christina [1 ]
Resch, Heinrich [1 ]
机构
[1] Med Univ Vienna, Acad Teaching Hosp, St Vincent Hosp, Dept Med 2,VINFORCE Study Grp, A-1060 Vienna, Austria
[2] WGKK & AUVA Trauma Ctr Meidling, Hanusch Hosp, Dept Med 1, Ludwig Boltzmann Inst Osteol, A-1140 Vienna, Austria
[3] Med Univ Graz, Div Endocrinol & Nucl Med, Graz, Austria
关键词
Osteogenesis imperfecta; Adults; BMD; Hip structure analysis (HSA); HIP STRUCTURAL-ANALYSIS; BONE-MINERAL DENSITY; FRACTURE RISK; INTRAVENOUS PAMIDRONATE; POSTMENOPAUSAL WOMEN; COMPUTED-TOMOGRAPHY; CONTROLLED-TRIAL; TRIPLE-HELIX; CHILDREN; STRENGTH;
D O I
10.1007/s00256-012-1512-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
Osteogenesis imperfecta (OI) is an inherited disorder characterized by increased bone fragility with recurrent fractures that leads to skeletal deformities in severe cases. Consequently, in most OI patients, the hip is the only reliable measuring site for estimating future fracture risk. The aim of the study was to assess the applicability of hip structure analysis (HSA) by DXA in adult patients with osteogenesis imperfecta. We evaluated bone mineral density (BMD) and hip structure analysis (HSA) by DXA, including cross-sectional area (CSA), cross-sectional moment of inertia (CSMI) and femoral strength index (FSI) in 30 adult patients with different types of OI and 30 age-matched healthy controls (CO). The OI total group (OI-tot) was divided into two subgroups: the mild OI I group (OI-I) and the more severe OI III and IV group (OI-III-IV). The mean neck BMD of OI-I and OI-III-IV were significantly lower compared to CO (-15.9 %, p < 0.005 and -37.5 %, p < 0.001 respectively). Similar results were observed at trochanter and total hip. CSA and the CSMI value were significantly lower for OI-I (-23.2 %, p < 0.001) and OI-III-IV (-45.9 %, p < 0.001) in comparison to CO. In addition, significant differences were found between the mild OI-I and the severe OI-III-IV group (-29.6 %, p < 0.05). FSI was significantly decreased in the OI-III-IV (25.7 %, p < 0.05) in comparison to the CO. Furthermore, significant correlations between BMD and HSA and between HSA and height and weight were found in osteogenesis imperfecta and controls. BMD measurement in osteogenesis imperfecta patients is very critical. The combination of BMD and geometric structural measurements at the hip in osteogenesis imperfecta patients may represent an additional helpful means in estimating bone strength and fracture risk.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 41 条
[1]
Contribution of hip strength indices to hip fracture risk in elderly men and women [J].
Ahlborg, HG ;
Nguyen, ND ;
Nguyen, TV ;
Center, JR ;
Eisman, JA .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (10) :1820-1827
[2]
Femoral Neck Bone Strength Estimated by Hip Structural Analysis (HSA) in Swedish Caucasians Aged 6-90 Years [J].
Alwis, Gayani ;
Karlsson, Caroline ;
Stenevi-Lundgren, Susanna ;
Rosengren, Bjorn E. ;
Karlsson, Magnus K. .
CALCIFIED TISSUE INTERNATIONAL, 2012, 90 (03) :174-185
[3]
Lack of Cyclophilin B in Osteogenesis Imperfecta with Normal Collagen Folding [J].
Barnes, Aileen M. ;
Carter, Erin M. ;
Cabral, Wayne A. ;
Weis, MaryAnn ;
Chang, Weizhong ;
Makareeva, Elena ;
Leikin, Sergey ;
Rotimi, Charles N. ;
Eyre, David R. ;
Raggio, Cathleen L. ;
Marini, Joan C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (06) :521-528
[4]
HSA: Beyond BMD with DXA [J].
Bonnick, Sydney Lou .
BONE, 2007, 41 (01) :S9-S12
[5]
Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists [J].
Bradbury, L. A. ;
Barlow, S. ;
Geoghegan, F. ;
Hannon, R. A. ;
Stuckey, S. L. ;
Wass, J. A. H. ;
Russell, R. G. G. ;
Brown, M. A. ;
Duncan, E. L. .
OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) :285-294
[6]
Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta [J].
Cabral, Wayne A. ;
Chang, Weizhong ;
Barnes, Aileen M. ;
Weis, MaryAnn ;
Scott, Melissa A. ;
Leikin, Sergey ;
Makareeva, Elena ;
Kuznetsova, Natalia V. ;
Rosenbaum, Kenneth N. ;
Tifft, Cynthia J. ;
Bulas, Dorothy I. ;
Kozma, Chahira ;
Smith, Peter A. ;
Eyre, David R. ;
Marini, Joan C. .
NATURE GENETICS, 2007, 39 (03) :359-365
[7]
Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: A 3-year randomized placebo-controlled trial [J].
Chevrel, G ;
Schott, AM ;
Fontanges, E ;
Charrin, JE ;
Lina-Granade, G ;
Duboeuf, F ;
Garnero, P ;
Arlot, M ;
Raynal, C ;
Meunier, PJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (02) :300-306
[8]
Femur strength index predicts hip fracture independent of bone density and hip axis length [J].
Faulkner, KG ;
Wacker, WK ;
Barden, HS ;
Simonelli, C ;
Burke, PK ;
Ragi, S ;
Del Rio, L .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 (04) :593-599
[9]
New perspectives on osteogenesis imperfecta [J].
Forlino, Antonella ;
Cabral, Wayne A. ;
Barnes, Aileen M. ;
Marini, Joan C. .
NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (09) :540-557
[10]
Intravenous bisphosphonate therapy increases radial width in adults with osteogenesis imperfecta [J].
Gatti, D ;
Viapiana, O ;
Lippolis, I ;
Braga, V ;
Prizzi, R ;
Rossini, M ;
Adami, S .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (08) :1323-1326